Can you provide the upcoming earnings date for SALARIUS PHARMACEUTICALS INC?
SALARIUS PHARMACEUTICALS INC (SLRX) will report earnings on 2026-03-19, after the market close.
SALARIUS PHARMACEUTICALS INC (SLRX) Forecast, Price Target & Analyst Ratings
NASDAQ:SLRX • US79400X5032
Current stock price
0.84 USD
+0.19 (+29.23%)
At close:
0.835 USD
-0.01 (-0.6%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SALARIUS PHARMACEUTICALS INC (SLRX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$6.01
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.84 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
SLRX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about SLRX.
In the previous month the buy percentage consensus was at a similar level.
SLRX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-03-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-25 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$6.01
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 12.22%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
SLRX is expected to report earnings on 3/19/2026. The consensus EPS estimate for the next earnings is -6.01 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2025 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.465M 313.45% | 5.233M 51.03% | 1.84M -64.84% | -100.00% | 12.113M | ||||
| EBITDA YoY % growth | -8.138M 60.27% | -7.768M 4.54% | -12.794M -64.69% | N/A -79.53% | N/A 43.90% | N/A 55.53% | N/A | N/A | |
| EBIT YoY % growth | -8.265M 60.09% | -7.786M 5.79% | -12.813M -64.55% | -22.734M -79.31% | -18.21M 43.87% | -6.242M 55.53% | -6.25M -8.99% | N/A | |
| Operating Margin | -238.52% | -148.79% | -696.28% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -1,650.00 72.77% | -900.00 45.45% | -911.27 -44.00% | -5.25 99.59% | -4.12 21.55% | -9.35 -126.98% | -4.39 53.11% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -6.01 12.22% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SALARIUS PHARMACEUTICALS INC / SLRX Forecast FAQ
What are the consensus estimates for SLRX stock next earnings?
The consensus EPS estimate for the next earnings of SALARIUS PHARMACEUTICALS INC (SLRX) is -6.01 USD and the consensus revenue estimate is 0 USD.